S&P 500   3,118.56 (-0.06%)
DOW   28,001.99 (-0.01%)
QQQ   202.55 (-0.18%)
GE   11.38 (-1.22%)
T   39.49 (-0.03%)
DIS   148.09 (+2.36%)
S&P 500   3,118.56 (-0.06%)
DOW   28,001.99 (-0.01%)
QQQ   202.55 (-0.18%)
GE   11.38 (-1.22%)
T   39.49 (-0.03%)
DIS   148.09 (+2.36%)
S&P 500   3,118.56 (-0.06%)
DOW   28,001.99 (-0.01%)
QQQ   202.55 (-0.18%)
GE   11.38 (-1.22%)
T   39.49 (-0.03%)
DIS   148.09 (+2.36%)
S&P 500   3,118.56 (-0.06%)
DOW   28,001.99 (-0.01%)
QQQ   202.55 (-0.18%)
GE   11.38 (-1.22%)
T   39.49 (-0.03%)
DIS   148.09 (+2.36%)
Log in

Alphatec Stock Price, Forecast & Analysis (NASDAQ:ATEC)

$7.29
+0.11 (+1.53 %)
(As of 11/18/2019 12:25 PM ET)
Today's Range
$7.14
Now: $7.29
$7.30
50-Day Range
$4.72
MA: $5.76
$7.19
52-Week Range
$1.18
Now: $7.29
$7.24
Volume5,759 shs
Average Volume453,419 shs
Market Capitalization$447.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.52
Alphatec Holdings, Inc, a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$91.69 million
Book Value$0.94 per share

Profitability

Net Income$-28,980,000.00

Miscellaneous

Employees195
Market Cap$447.31 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.


Alphatec (NASDAQ:ATEC) Frequently Asked Questions

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How were Alphatec's earnings last quarter?

Alphatec Holdings Inc (NASDAQ:ATEC) released its quarterly earnings results on Wednesday, October, 30th. The medical technology company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.03. The medical technology company had revenue of $29.20 million for the quarter, compared to analyst estimates of $26.85 million. Alphatec had a negative return on equity of 151.54% and a negative net margin of 47.55%. View Alphatec's Earnings History.

When is Alphatec's next earnings date?

Alphatec is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Alphatec.

What price target have analysts set for ATEC?

4 equities research analysts have issued 12-month target prices for Alphatec's stock. Their forecasts range from $6.00 to $10.00. On average, they anticipate Alphatec's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View Analyst Price Targets for Alphatec.

What is the consensus analysts' recommendation for Alphatec?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alphatec.

Has Alphatec been receiving favorable news coverage?

News coverage about ATEC stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Alphatec earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the medical technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Alphatec.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the folowing people:
  • Mr. Patrick S. Miles, Exec. Chairman & CEO (Age 53)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 55)
  • Mr. Terry M. Rich, Consultant (Age 51)
  • Mr. Jeffrey P. Rydin, Director (Age 52)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 50)

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Essex Investment Management Co. LLC (0.52%), Jackson Financial Management (0.37%), Russell Investments Group Ltd. (0.30%), Perkins Capital Management Inc. (0.14%), Rhumbline Advisers (0.05%) and Cadence Capital Management LLC (0.03%). Company insiders that own Alphatec stock include Craig E Hunsaker, Evan Bakst, Jeffrey G Black and Kelli Mari Howell. View Institutional Ownership Trends for Alphatec.

Which institutional investors are buying Alphatec stock?

ATEC stock was purchased by a variety of institutional investors in the last quarter, including Jackson Financial Management, Russell Investments Group Ltd., Essex Investment Management Co. LLC, Perkins Capital Management Inc., Cadence Capital Management LLC, Envestnet Asset Management Inc., Valeo Financial Advisors LLC and Rhumbline Advisers. Company insiders that have bought Alphatec stock in the last two years include Evan Bakst and Kelli Mari Howell. View Insider Buying and Selling for Alphatec.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $7.29.

How big of a company is Alphatec?

Alphatec has a market capitalization of $447.31 million and generates $91.69 million in revenue each year. The medical technology company earns $-28,980,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Alphatec employs 195 workers across the globe.View Additional Information About Alphatec.

What is Alphatec's official website?

The official website for Alphatec is http://www.atecspine.com/.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]


MarketBeat Community Rating for Alphatec (NASDAQ ATEC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  239 (Vote Outperform)
Underperform Votes:  317 (Vote Underperform)
Total Votes:  556
MarketBeat's community ratings are surveys of what our community members think about Alphatec and other stocks. Vote "Outperform" if you believe ATEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel